Company Analysis

Kiora Pharmaceuticals, Inc. (KPRX)

Nasdaq: KPRX · Pharmaceutical Preparations · Encinitas, CA · filing with the SEC since 2006
Grade4.9
◀ Past 1.9● Present 5.3▶ Future 6.5
5 est.

Who runs Kiora Pharmaceuticals, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Strem Brian M.
President and CEO. First filing Aug 2021, latest Jul 2, 2026, 2 filings in all.
Officers reporting now
3
of 9 people with a filing in the last fifteen months
Directors reporting now
6
30 people on the record since 2015
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Strem Brian M.President and CEOAug 2021Jul 2, 2026none
Tosca MelissaCFOSep 2022Jul 2, 2026none
Daniels Eric JosephChief Development OfficerOct 2021Apr 2, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Hollander DaviddirectorDec 2021Jun 12, 2026none
Parsons ErindirectorFeb 2022Jun 12, 2026none
Shapiro ArondirectorApr 2021Jun 12, 2026none
Stengone Carmine N.directorAug 2023Jun 12, 2026none
Tyle PraveendirectorFeb 2015Jun 12, 2026none
Walters-Hoffert LisadirectorJul 2024Jun 12, 2026none
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Lane Keith J.otherSep 2026Sep 17, 2026none
Earlier names on the record22, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton KPRX · research, not advice